5-fluorodopamine has been researched along with yohimbine in 2 studies
| Studies (5-fluorodopamine) | Trials (5-fluorodopamine) | Recent Studies (post-2010) (5-fluorodopamine) | Studies (yohimbine) | Trials (yohimbine) | Recent Studies (post-2010) (yohimbine) |
|---|---|---|---|---|---|
| 76 | 8 | 16 | 5,893 | 253 | 532 |
| Protein | Taxonomy | 5-fluorodopamine (IC50) | yohimbine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0353 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.02 | |
| D(2) dopamine receptor | Homo sapiens (human) | 2.06 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0428 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0466 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.126 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.013 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.126 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.074 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.689 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, PC; Goldstein, DS; Grossman, E; Kopin, IJ; Szemeredi, K | 1 |
| Cannon, RO; Dendi, R; Eisenhofer, G; Esler, MD; Frank, SM; Goldstein, DS; Holmes, C; Sharabi, Y | 1 |
1 trial(s) available for 5-fluorodopamine and yohimbine
| Article | Year |
|---|---|
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; Coronary Circulation; Dihydroxyphenylalanine; Dopamine; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Hypotension, Orthostatic; Lower Body Negative Pressure; Male; Methoxyhydroxyphenylglycol; Myocardium; Norepinephrine; Reference Values; Sympathetic Nervous System; Syncope, Vasovagal; Syndrome; Tachycardia; Tomography, Emission-Computed; Yohimbine | 2002 |
1 other study(ies) available for 5-fluorodopamine and yohimbine
| Article | Year |
|---|---|
Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.
Topics: Animals; Desipramine; Dopamine; Exocytosis; Male; Nitroprusside; Normetanephrine; Rats; Reserpine; Sympathetic Nervous System; Tissue Distribution; Tomography, Emission-Computed; Tritium; Yohimbine | 1990 |